Skip to main content
. 2018 Mar 4;26(4):651–657. doi: 10.1002/oby.22132

Figure 2.

Figure 2

Insulin sensitivity (glucose uptake) at baseline (black bars) and after 3 months of treatment (white bars) in the placebo (PLA) and vitamin D (VITD) groups; *P = 0.02.